不受影响的基础设施和运输对象exchange of information with patient organizations as detailed in ourCommitment to Patients and Caregivers.Patient organizations are key partners inour decision-making throughout the medicines'lifecycle。We believe that incorporating the patient perspective in our decision-making can help to develop better medicines for patients。
Novartis engages with patient organizations in recognition of their unique expertise and perspectives.We fully respect their independence and integrity.Patient organizations are neither required nor encouraged to promote or endorse Novartis products and services.We do not initiate or drive the creation of netitions and nitivet to be the sole funder of any patient organization。
本发明提供了一种空气调节器，空气调节器their time and expenses according to local laws and regulations on afair market value（FMV）basis，following an established process and methodology.We believe patient organization representatives should receive fair remuneration for the services or consultancy they provide based on their experience，expertise，and time.Committing to FMV is essential to build trust with the patient community and to strengthen our approach to patient engagement in a transparent，fair，and consistent manner。
Novartis discloses monetary and non-monetary support to patient organizations around the globe by June 30 in compliance with theEFPIA Codeand other industry codes such as thePhRMA Principles on Interactions with Patient Organizationto support its ethical and transparent relationships with patient organizations。